1-90 of about 90 matches for site:www.patentsencyclopedia.com decrease respiratory
https://www.patentsencyclopedia.com/app/20220296839
which manufacturability and usability of respiratory masks are improved. A respiratory mask is disclosed for
https://www.patentsencyclopedia.com/app/20220280113
percent of ribcage excursion, tidal volume, minute volume, inhale airflow velocity, exhale airflow velocity, respiratory rhythm, and respiratory
https://www.patentsencyclopedia.com/app/20220281846
0015] The improvement in respiratory function may be selected from a decrease in the
https://www.patentsencyclopedia.com/app/20220280450
PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED RESPIRATORY INFECTIONS - Patent application Inventors list Assignees list
Surface-Enhanced Copper Filter for Air Purification and System and Method for Using - Patent applica
https://www.patentsencyclopedia.com/app/20220297039
biological contaminants can also trigger allergic reactions, including asthma. Health problems caused by biological contaminants include respiratory symptoms, such sneezing, watery
https://www.patentsencyclopedia.com/app/20220282739
of conditioned gas for a future respiratory cycle, electronic control circuitry can decrease the amount
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_8
may be caused by coronaviruses, including severe acute respiratory syndrome coronavirus and severe acute respiratory syndrome coronavirus. N-Butyloxycarbonyl
https://www.patentsencyclopedia.com/app/20220296799
region in which the third braiding angle is configured to gradually decrease from the first
VETERINARY BROMHEXINE HYDROCHLORIDE SOLUBLE POWDER, PREPARATION METHOD AND USE THEREOF - Patent appl
https://www.patentsencyclopedia.com/app/20220233472
a mixing equipment. 10. A drug for auxiliary treatment of respiratory diseases of livestock
https://www.patentsencyclopedia.com/app/20220296847
a blood pressure sensor, a pulse oximetry (SpO.sub.2) sensor, a respiratory rate monitor, a
https://www.patentsencyclopedia.com/app/20220233987
well-established mechanism for disinfecting against various viruses, bacteria, fungi, etc. that cause acute respiratory syndromes thereby helping decrease
https://www.patentsencyclopedia.com/app/20220296836
of respiration and sleep therapy for supplying a patient with respiratory gas by means of
Treatment of Acute Medical Conditions by Stimulating the Neural Activity of a Nerve Supplying the Sp
https://www.patentsencyclopedia.com/app/20220233856
a useful way to treat acute medical conditions, such as trauma, hemorrhaging, shock, acute respiratory distress syndrome (ARDS), severe
https://www.patentsencyclopedia.com/app/20220298477
A method for treating or preventing radiation-induced lung injury, acute lung injury, acute respiratory distress syndrome, idiopathic pulmonary
METHOD AND USE OF COMPOSITIONS COMPRISING LIGNOSULFONATE FOR ATTENUATION OF SARS-CoV-2 VIRUS REPLICA
https://www.patentsencyclopedia.com/app/20220280556
of a composition comprising lignosulfonate for attenuation of severe acute respiratory syndrome coronavirus 2 (SARS
AGENT FOR TREATING OR PREVENTING CANCER, AND COMBINATION OF RF PATHWAY INHIBITOR AND MEK INHIBITOR F
https://www.patentsencyclopedia.com/app/20220280521
with roseoflavin (RoF), and a relative survival rate was calculated assuming that mitochondrial respiratory chain activity corresponded to
https://www.patentsencyclopedia.com/hgl/02-17-22/02-17-22_8
based assays. Our study also demonstrates that brazilin and theaflavin-3, 3′-digallate, curcumin, decrease the activity
https://www.patentsencyclopedia.com/hgl/07-28-22/07-28-22_27
inventors show that antisense oligonucleotides masking the secretory polyadenylation signal induce a decrease in the
https://www.patentsencyclopedia.com/inventor/jeffrey-e-stahmann-ramsey...
the invention are related to methods and devices for respiratory or cardiac disease detection
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_4
in a second rotation direction, opposite to the first rotation direction, will decrease the gap
https://www.patentsencyclopedia.com/hgl/08-04-22/08-04-22_10
i) to overexpress BLIMP1 and/or (ii) to knock-out or decrease expression of BCL6
https://www.patentsencyclopedia.com/app/20220296832
according to claim 1, where the patient connector is a respiratory connector. 15. The
https://www.patentsencyclopedia.com/inventor/dennis-j-rivet-portsmouth...
utility modules comprising a first module operable in a digestive or respiratory tract to engage
https://www.patentsencyclopedia.com/app/20090269329
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20090271213
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20090271010
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20090271120
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20220296550
of one or more embodiments provided by the present disclosure is to decrease a length
https://www.patentsencyclopedia.com/app/20220282279
or MERS-CoV), ebola virus, Marburg virus, human parainfluenza virus 1, measles virus, mumps virus, human respiratory syncytial virus, vesicular stomatitis
https://www.patentsencyclopedia.com/app/20220296544
demonstrated its ability as an antiviral agent against hepatitis B virus, Epstein Barr virus, severe acute respiratory syndrome (SARS), coronavirus, Japanese
https://www.patentsencyclopedia.com/app/20220234703
tanks, the gas volume used in every breath and the respiratory rate. Typical breathing volumes
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_8
09-08 20220280450 PREVENTION AND TREATMENT OF CORONAVIRUS AND RELATED RESPIRATORY INFECTIONS - The present
https://www.patentsencyclopedia.com/app/20220235360
inventors show that antisense oligonucleotides masking the secretory polyadenylation signal induce a decrease in the
https://www.patentsencyclopedia.com/app/20220282068
Moreover, there has been some modeling studies that suggest the sulfate-based aerosols could decrease rainfall in Asia
https://www.patentsencyclopedia.com/hgl/09-01-22/09-01-22_10
vectors, pseudotyped with hemagglutinin-neuraminidase (HN) and fusion (F) proteins from a respiratory paramyxovirus, comprising a
https://www.patentsencyclopedia.com/app/20220233468
i.e., severe acute respiratory syndrome (SARS) in 2002 to 2003, Middle East respiratory syndrome (MERS) in
https://www.patentsencyclopedia.com/hgl/09-01-22/09-01-22_11
09-01 20220273901 OUTLET CONNECTION ASSEMBLY - A connection assembly for a respiratory therapy system, comprising: an
COPPER-ATSM FOR TREATING NEURODEGENERATIVE DISORDERS ASSOCITED WITH MITOCHONDRIAL DYSFUNCTION - Pate
https://www.patentsencyclopedia.com/app/20220280561
disorders caused by SMARCAL1 mutations, neurological disorders caused by KIF1A mutations, Huntington's disease, SMA with respiratory distress and Charcot
https://www.patentsencyclopedia.com/app/20220233214
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
PATIENT BIOMARKER MONITORING WITH OUTCOMES TO MONITOR OVERALL HEALTHCARE DELIVERY - Patent applicati
https://www.patentsencyclopedia.com/app/20220238197
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220233254
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220233252
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/hgl/09-08-22/09-08-22_23
at which the bacterium is grown, it is feasible to increase or decrease the amount
https://www.patentsencyclopedia.com/app/20220280320
failure, and venous disease. Obesity can also cause orthopedic problems, skin problems and respiratory difficulties. [0007] A
MEASUREMENT DEVICE THROUGH WHICH BREATHING GAS CAN FLOW FOR MEASURING GAS COMPONENTS OF THE BREATHIN
https://www.patentsencyclopedia.com/app/20220280067
devices for capturing the CO.sub.2 fraction in the respiratory gas through infrared spectroscopy
https://www.patentsencyclopedia.com/app/20220282221
iFGEs and iHTNs. Consequently, EDC treatment decreased maximal mitochondrial respiration and spare respiratory capacity in iFGEs
https://www.patentsencyclopedia.com/app/20090271008
muscular disorder, a nervous system disorder, a reproductive disorder, a respiratory disorder, a skeletal
https://www.patentsencyclopedia.com/app/20220235361
pathological state is cystic fibrosis, primary ciliary dyskinesia, chronic bronchitis, chronic obstructive pulmonary disease (COPD), asthma, respiratory tract infections, lung carcinoma
https://www.patentsencyclopedia.com/app/20220233488
mucosal membranes/tissues, optionally, tissues of the lung and the respiratory tract; and cardiovascular
https://www.patentsencyclopedia.com/app/20220233191
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220238216
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
https://www.patentsencyclopedia.com/app/20220233102
conductance, peripheral temperature, tissue perfusion pressure, coughing and sneezing, gastrointestinal motility, gastrointestinal tract imaging, respiratory tract bacteria, edema, mental
GENERATION OF CTL LINES WITH SPECIFICITY AGAINST MULTIPLE TUMOR ANTIGENS OR MULTIPLE VIRUSES - Paten
https://www.patentsencyclopedia.com/app/20220282218
Epstein-Barr virus (EBV), cytomegalovirus (CMV), and herpes simplex virus, as well as by respiratory viruses such as respiratory
Epitope-Based Approach for Allergy Treatments and Inhibitors for Crohn's Disease - Patent applicatio
https://www.patentsencyclopedia.com/app/20220233686
epitopes aimed by in-silica tools can result in an increase or decrease, in the
METHODS AND COMPOSITIONS FOR TREATING INFECTION AND INFLAMMATION WITH SELENOCYANATE - Patent applica
https://www.patentsencyclopedia.com/app/20220280467
consisting of cystic fibrosis, pneumonia, viral pulmonary infection, bacterial pulmonary infection, fungal pulmonary infection, acute respiratory distress syndrome, asthma, chronic
https://www.patentsencyclopedia.com/app/20220236249
of sputum characteristics. BACKGROUND OF THE INVENTION [0003] Many patients with chronic respiratory diseases, such as, for
https://www.patentsencyclopedia.com/app/20220283278
breathing, such that different subsets of the ultrasound data are acquired under different respiratory motion conditions. 8. The
https://www.patentsencyclopedia.com/app/20220235393
s). For example, 4 log.sub.10 of porcine reproductive and respiratory syndrome (PRRS) virus, a
https://www.patentsencyclopedia.com/app/20220285031
test may be, for example, a brain wave test, a respiratory function test, a
https://www.patentsencyclopedia.com/app/20220280062
The technology can be used to detect viral protein, such as severe acute respiratory syndrome coronavirus 2 (SARS
https://www.patentsencyclopedia.com/app/20210322690
OT treatment condition in comparison to both Placebo (p=0.011; mean decrease=17%, SE decrease 6
COMPOSITIONS AND METHODS FOR IMPROVING MITOCHONDRIAL FUNCTION AND TREATING NEURODEGENERATIVE DISEASE
https://www.patentsencyclopedia.com/app/20220280475
used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase
https://www.patentsencyclopedia.com/inventor/mcallister-us-5/
the current. The processor can output a command specifying an increase or decrease in the
https://www.patentsencyclopedia.com/app/20220096763
its anterior part with transitional epithelium, with a gradual transition posterior to respiratory epithelium. The nasal
https://www.patentsencyclopedia.com/app/20090101838
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090101846
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090101841
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090104179
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20090104113
the optical energy 114 to become biologically inactive, to partially increase or decrease a level
https://www.patentsencyclopedia.com/app/20220280507
rate, decreased blood pressure, urinary and fecal incontinence, possibly deaths due to respiratory and circulatory
https://www.patentsencyclopedia.com/app/20220235313
enzootic pneumonia and is a factor in the porcine respiratory disease complex (PRDC) along
https://www.patentsencyclopedia.com/app/20220282257
amount effective increase one or more of lipolysis, fatty acid oxidation, lipid metabolism or decrease lipogenesis in adipose
https://www.patentsencyclopedia.com/app/20220233539
pancreas; retroperitoneum; peritoneum, omentum, and mesentery; other digestive); cancers of the respiratory system (nasal cavity, middle
https://www.patentsencyclopedia.com/app/20220233540
pancreas; retroperitoneum; peritoneum, omentum, and mesentery; other digestive); cancers of the respiratory system (nasal cavity, middle
ELUTION OF MICROPARTICLES BY SIZE EXCLUSION CHROMATOGRAPHY USING WATER AS A MOBILE PHASE - Patent ap
https://www.patentsencyclopedia.com/app/20220236277
urine, tears, milk, lymph fluid, synovial fluid, bronchoalveolar lavage, amniotic fluid, saliva, ocular fluid, ascites, or respiratory droplets. [0020] The
https://www.patentsencyclopedia.com/app/20220280682
with medical devices or blood product transfusions. Three major sites of HAIs are bloodstream, respiratory tract, and urinary
A METHOD AND APPARATUS FOR TREATMENT OF DRUG RESISTANT HYPERTENSION ASSOCIATED WITH IMPAIRED LEFT VE
https://www.patentsencyclopedia.com/app/20220282962
heart rale-based modulation. Sensors inside the pacemaker, such as accelerometers and respiratory movement detectors, regulate pacemaker
https://www.patentsencyclopedia.com/app/20220233114
brain and heart, and continued low oxygen levels may lead to respiratory or cardiac arrest. In
https://www.patentsencyclopedia.com/app/20220236287
even death. The varying symptomatology, even shared with other acute cardiothoracic and respiratory diseases, can delay the
ENHANCING THE ANTIVIRAL EFFICACY OF RNA VIRUS INHIBITION BY COMBINATION WITH MODULATORS OF PYRIMIDIN
https://www.patentsencyclopedia.com/app/20220280513
benefit of the present invention can also, or alternatively, be a decrease in the
https://www.patentsencyclopedia.com/app/20220233163
rate and heart rhythm, chest motion sensors to monitor the respiratory rate, and thermometer
https://www.patentsencyclopedia.com/app/20220233190
FIGS. 3E and 3F. [0031] In order to avoid or decrease the possibility
https://www.patentsencyclopedia.com/inventor/yujiro-7/
values, body temperature, the degree of anger or anxiety, and respiratory rate. 01-03-2013
https://www.patentsencyclopedia.com/app/20220281951
also by use of a K74A mutation. Other mutations that caused an overall decrease in ligand
https://www.patentsencyclopedia.com/app/20220280526
such as high costs, difficult application routes and systemic side effects such as upper respiratory tract infections, see Wasilewska
https://www.patentsencyclopedia.com/app/20220280263
fraught with numerous potential adverse side effects such as overdose, suppression of the respiratory drive, constipation, and
https://www.patentsencyclopedia.com/app/20090149708
may be surgically or otherwise provided where desired within a bodily system (e.g., digestive, respiratory, or circulatory system(s
https://www.patentsencyclopedia.com/app/20220279797
demonstrated against the hepatitis A and C virus and respiratory syncytial virus (RSV). [0010
https://www.patentsencyclopedia.com/app/20220236261
scanning cannot detect asymptomatic infections, nor can it distinguish the novel coronavirus from other respiratory illnesses. Swab-type coronavirus
NUTRITIONAL COMPOSITION FOR GASTROINTESTINAL ENVIRONMENT TO PROVIDE IMPROVED MICROBIOME AND METABOLI
https://www.patentsencyclopedia.com/app/20220232874
relatedness, object recognition [0006] 3. Support social-emotional development [0007] 4. Support better sleep [0008] 5. Decrease stress, reduce crying, colic